Ping Dai Selected Research

Ping Dai Research Topics

Disease

6	Neoplasms (Cancer) 10/2016 - 09/2009
3	Spinal Cord Injuries (Spinal Cord Injury) 10/2016 - 04/2015
3	Colorectal Neoplasms (Colorectal Cancer) 01/2014 - 11/2009
2	Necrosis 05/2019 - 07/2014
2	Carcinogenesis 01/2018 - 09/2009
2	Hyperalgesia 10/2016 - 10/2016
2	Edema (Dropsy) 09/2016 - 11/2012
2	Neoplasm Metastasis (Metastasis) 11/2013 - 11/2009
2	Lymphatic Metastasis 11/2013 - 11/2009
1	Non-alcoholic Fatty Liver Disease 04/2022
1	Obesity 01/2022
1	Pulmonary Arterial Hypertension 01/2022
1	Metabolic Diseases (Metabolic Disease) 01/2022
1	Breast Neoplasms (Breast Cancer) 01/2021
1	Anemia 05/2019
1	Hypertrophy 05/2019
1	Infections 05/2019
1	Inflammation (Inflammations) 05/2019
1	Atherosclerosis 05/2019
1	Vascular Remodeling 05/2019
1	Disease Resistance 02/2018
1	Leukopenia 01/2018
1	Thrombocytopenia (Thrombopenia) 01/2018
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2018
1	Bone Neoplasms (Bone Cancer) 10/2016
1	Pain (Aches) 10/2016
1	Ischemia 09/2016
1	Pneumonia (Pneumonitis) 09/2016
1	Acute Lung Injury 09/2016
1	Cicatrix (Scar) 04/2015
1	Gliosis 04/2015
1	Contracture 01/2015
1	Dermatitis 05/2014
1	Hypoxia (Hypoxemia) 01/2014
1	Cyclothymic Disorder 11/2013
1	Bipolar Disorder (Manic Depressive Psychosis) 11/2013
1	Mania (Manias) 11/2013
1	Headache (Headaches) 10/2013
1	Schizophrenia (Dementia Praecox) 10/2013
1	Hallucinations (Hallucination) 10/2013
1	Stomach Neoplasms (Stomach Cancer) 10/2013
1	Type 2 Diabetes Mellitus (MODY) 04/2013
1	Lung Injury 11/2012
1	Brain Ischemia (Cerebral Ischemia) 11/2012
1	Nasopharyngeal Carcinoma 08/2012
1	Adenoma (Adenomas) 01/2012
1	Glioblastoma (Glioblastoma Multiforme) 12/2010

Drug/Important Bio-Agent (IBA)

4	Proteins (Proteins, Gene)FDA Link 05/2019 - 09/2009
3	AcidsIBA 11/2013 - 11/2009
3	protoporphyrin IXIBA 11/2013 - 11/2009
3	Connexin 43 (Connexin43)IBA 04/2009 - 01/2008
2	AmmoniaIBA 05/2019 - 02/2018
2	Transcription Factors (Transcription Factor)IBA 01/2018 - 12/2010
2	Small Interfering RNA (siRNA)IBA 10/2016 - 01/2008
2	Brain-Derived Neurotrophic Factor (BDNF)IBA 10/2016 - 11/2012
2	NAD (NADH)IBA 01/2014 - 01/2012
2	Hemoglobins (Hemoglobin)IBA 01/2014 - 01/2012
2	salicylhydroxamic acid (SHAM)IBA 10/2013 - 11/2012
2	Messenger RNA (mRNA)IBA 11/2012 - 09/2009
1	CholesterolIBA 04/2022
1	Phosphodiesterase 5 InhibitorsIBA 01/2022
1	ambrisentan FDA Link 01/2022
1	Uncoupling Protein 1IBA 01/2022
1	salinomycinIBA 01/2021
1	ErbB Receptors (EGF Receptor)IBA 01/2021
1	Therapeutic UsesIBA 01/2021
1	tocophersolanIBA 01/2021
1	AntioxidantsIBA 05/2019
1	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 01/2018
1	Morphine (MS Contin)FDA LinkGeneric 10/2016
1	Platelet-Derived Growth FactorIBA 10/2016
1	Aquaporin 4IBA 09/2016
1	p38 Mitogen-Activated Protein KinasesIBA 09/2016
1	Complementary DNA (cDNA)IBA 04/2015
1	VimentinIBA 04/2015
1	SEA 0400IBA 01/2015
1	ThapsigarginIBA 01/2015
1	RyanodineIBA 01/2015
1	SaponinsIBA 01/2015
1	CalciumIBA 01/2015
1	Verapamil (Calan)FDA LinkGeneric 01/2015
1	Picryl Chloride (Trinitrochlorobenzene)IBA 05/2014
1	Oxygen (Dioxygen)IBA 01/2014
1	Phenobarbital (Luminal)FDA Link 01/2014
1	Second-Generation Antidepressive AgentsIBA 11/2013
1	Monoamine Oxidase Inhibitors (Monoamine Oxidase Inhibitor)IBA 11/2013
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 11/2013
1	Tricyclic Antidepressive Agents (Tricyclic Antidepressants)IBA 11/2013
1	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 11/2013
1	Antidepressive Agents (Antidepressants)IBA 11/2013
1	Photosensitizing Agents (Photosensitizers)IBA 10/2013
1	Insulin (Novolin)FDA Link 04/2013
1	Polysaccharides (Glycans)IBA 08/2012
1	Biomarkers (Surrogate Marker)IBA 01/2012
1	Eosine Yellowish-(YS) (Eosin)IBA 11/2009

Therapy/Procedure

3	Therapeutics 01/2021 - 11/2013
1	Drug Therapy (Chemotherapy) 01/2018
1	Spinal Injections 10/2016
1	Ligation 07/2014
1	Transcranial Magnetic Stimulation 10/2013